<DOC>
	<DOC>NCT01083290</DOC>
	<brief_summary>Objective is to investigate pharmacokinetics and to estimate the level of dose linearity of spironolactone and its metabolites canrenone and 7Î±-thiomethylspirolactone from Spironolactone 25 mg, 50 mg and 100 mg Tablets</brief_summary>
	<brief_title>Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets</brief_title>
	<detailed_description />
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Subjects with normal findings as determined by baseline history, physical examination and vital signs, haemogram, biochemistry, infectious disease screening, urinalysis, 12 lead ECG Any condition requiring regular concomitant medication or likely to need any concomitant medication during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>spironolactone</keyword>
	<keyword>linearity of pharmacokinetics</keyword>
	<keyword>Healthy volunteers</keyword>
</DOC>